Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 18 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-18-2022-2

Zydus Lifesciences Limited has informed the Exchange about press release dated 18-Apr-2022 titled ���Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection���

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases